Fundraising FoxMEI Pharma
San Diego, US · Delaware corporation · 10 known investors
Find your way into MEI Pharma
Sign up to see every warm intro you have to MEI Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MEI Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lite Strategy, Inc. (NASDAQ: LITS) is a publicly traded treasury company that accumulates and manages Litecoin (LTC) holdings, aiming to increase LTC exposure per share for its shareholders. It positions itself as a way for public-market investors to gain exposure to Litecoin.
Founders & leadership
Board
Investors · 10
How we know: Aisling Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: GSR's portfolio page · Not right? Tell us
How we know: funding news · biocentury.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Primitive Ventures's portfolio page · Not right? Tell us
How we know: biocentury.com · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Also in the syndicate · 2
Reported raises · per SEC filings
Form D private placements$75M disclosed across 1 of 2 rounds · 2018–2025
▶$75MraisedMay 2018 · 20 investors · PharmaceuticalsRule 506(b)
- Frederick W. DriscollDirector
- Christine A. WhiteDirector
- David M. UrsoExecutive Officer
- Nicholas R. GloverDirector
- William D. RueckertDirector
- Daniel P. GoldExecutive Officer, Director
- Kevan E. ClemensDirector
- Thomas C. ReynoldsDirector
- Robert D. MassExecutive Officer
- Brian G. DrazbaExecutive Officer
- Charles V. Baltic IIIDirector
- Offering amount
- $75M
- Amount sold
- $75M
- Sales commissions
- $4.5M
- Placement agents
- Laidlaw & Company (UK) Ltd., Suntrust Investment Services, Inc., Oppenheimer & Co. Inc., Wells Fargo Securities, LLC, Stifel, Nicolaus & Company, Incorporated, BTIG, LLC
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does MEI Pharma do?
- Lite Strategy, Inc. (NASDAQ: LITS) is a publicly traded treasury company that accumulates and manages Litecoin (LTC) holdings, aiming to increase LTC exposure per share for its shareholders. It positions itself as a way for public-market investors to gain exposure to Litecoin.
- Who are MEI Pharma's investors?
- MEI Pharma's investors include 3B Future Health Fund, Aisling Capital, GSR, New Enterprise Associates (NEA), Primitive Ventures, Amzak Health, Biotechnology Value Fund, Vivo Capital.
- How much funding has MEI Pharma raised?
- MEI Pharma has disclosed $75M raised across 1 of its 2 known rounds.
- Where is MEI Pharma headquartered?
- MEI Pharma is headquartered in San Diego, US.